Skip to content
Screener

CorMedix CRMD Pre-Tax Income

Discontinued — last reported Q1 '26

Pre-Tax Income at other companies

Pfizer logo
PfizerPFE
-$653M-121%
Merck & Co. logo
Merck & Co.MRK
-$683M-114%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$53.55M+41.1%
IAR
Integra LifeSciencesIART
$4.74M+101%
ICU Medical logo
ICU MedicalICUI
$23.14M-31.3%
TFX
TeleflexTFX
$45.14M-36.1%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-21.4%
P/E3.2×
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: CorMedix’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021
Line itemFor the Three Months Ended March 31, 2026For the Three Months Ended March 31, 2025
Change in contingent consideration(4,199)-
Other non-operating (expense) income, net(268)519
Total Other (Expense) Income(8,013)519
Income before income taxes55,64520,644
Tax expense17,044
Net Income$38,601$20,644
Other Comprehensive Loss:
Unrealized loss from investments(1)(5)

Item 1. Unaudited Condensed Consolidated Financial Statements.

FAQ

What is CorMedix's pre-tax income?
CorMedix (CRMD) reported pre-tax income of $55.65M in Q1 2026.
How has CorMedix's pre-tax income changed year-over-year?
CorMedix's pre-tax income increased by 169.5% year-over-year, from $20.64M to $55.65M.
What is the long-term trend for CorMedix's pre-tax income?
Over 3 years (2021 to 2025), CorMedix's pre-tax income has grown at a 72.0% compound annual growth rate (CAGR), from -$29.46M to $150.02M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about CorMedix's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude